News

CCRI coordinates new FP7 funded project - DIRECT

The Children's Cancer Research Institute, the German Childhood Cancer Foundation, the St. Anna Children's Hospital and…

Winning projects in the Best of Biotech competition announced

Winning projects in the Best of Biotech competition announced

>> Life sciences business ideas off to a flying start

BOKU: New Christian Doppler Pilot Lab for rapid test systems for allergenic food contaminants

At Technopole Tulln the University of Natural Ressources and Applied Life Sciences opened a new Christian Doppler Pilot…

Intercell announces Q4 and preliminary full year 2007 results

Intercell announces Q4 and preliminary full year 2007 results First profitable year in company history – Vaccine against…

Intercell: Licensure application for Japanese Encephalitis vaccine submitted to Therapeutic Goods Administr...

Intercell: Licensure application for Japanese Encephalitis vaccine submitted to Therapeutic Goods Administration (TGA)…

Intercell completes Phase I clinical trial for an improved seasonal Influenza vaccine formulated with IC31(R)

Intercell completes Phase I clinical trial for an improved seasonal Influenza vaccine formulated with IC31(R)

»…

Marinomed Biotechnologie GmbH presents its first product - Carragelose(R) in the nasal spray COLDAMARIS pro...

Marinomed Biotechnologie GmbH presents its first product - Carragelose(R) in the nasal spray COLDAMARIS prophylactic

Affiris expands patent portfolio for Alzheimer's therapies

Affiris GmbH has secured another Europe-wide patent for an innovative method of treating Alzheimer's disease. This new…

Sanochemia: Withdrawal from planned investment in Countervail

Sanochemia: Withdrawal from planned investment in Countervail

>> Return of USD 560,000 planned as a deposit

>>…

Sanochemia: First Quarter Report 2007/2008

Sanochemia: First Quarter Report 2007/2008 Guidance for the year unchanged despite difficult Q1: continued revenue…

CHE-Ranking: University of Vienna's biology member of the excellence group

The Centre for Higher Education Development (CHE) is working to develop a Ranking of Excellent European Graduate…

Vienna biotech company TissueGnostics expands its business - by now in Japan and USA

The Austrian TissueGnostics Corporation, busy in the field of biomedical technical technologies, develops, manufactures…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.